COMMUNIQUÉS West-GlobeNewswire

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
09/12/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 9 December 2025 at 17.30 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons
09/12/2025
TUCSON, Ariz., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Serious but unacknowledged adverse events from COVID-19 vaccines occurred in the artificially foreshortened Pfizer/BioTech and Moderna trials, write Jeyanthi Kunadhasen, [...]
Vallarta Supermarkets Partners With evermore in First-Ever Benefit Card Integration, Expanding Access to Culturally Relevant Grocery Options for Health Plan Members Across California
09/12/2025
BENTONVILLE, Ark., Dec. 09, 2025 (GLOBE NEWSWIRE) -- evermore, the personalized health benefits platform redefining how people access the resources they need to live healthier lives, today announced a new partnership [...]
President of the Association of American Physicians and Surgeons (AAPS) Asks, ‘Would You Have Signed the Declaration of Independence?’
09/12/2025
TUCSON, Ariz., Dec. 09, 2025 (GLOBE NEWSWIRE) -- As we are approaching the 250 th anniversary of the Declaration of Independence, George L. Smith, III, M.D., reflects on the independence of physicians in the winter [...]
Climate Policy Is Based on a Meaningless Number, according to the Journal of American Physicians and Surgeons
09/12/2025
TUCSON, Ariz., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Trillions of dollars are being spent for the ostensible purpose of keeping the earth’s global mean surface temperature (GMST) from rising more than 1.5 or 2.0 degrees [...]
Idorsia’s treatment for insomnia disorder wins the inaugural Prix Galien Bridges Award in the ‘Best Biotechnology & Pharmaceutical Product’ category
09/12/2025
Idorsia’s dual orexin receptor antagonist, the first and only drug of its kind approved in Europe for the treatment of insomnia disorder, has been awarded the inaugural Prix Galien Bridges Award in the category of “Best [...]
SAFE - RESULTATS SEMESTRIELS 2025
09/12/2025
RESULTATS SEMESTRIELS 2025 Fleurieux-sur-l’Arbresle – France – 9 décembre 2025 – 18h - Safe (FR001400ZU25 – ALSAF) annonce ses résultats semestriels et avoir mis à la disposition du public et déposé auprès de l’Autorité [...]
Computerworld Names Aeroflow Health as One of the Best Midsize Places to Work in IT
09/12/2025
The recognition highlights the company’s commitment to creating a people-first, collaborative culture that fosters creativity and innovation ASHEVILLE, N.C., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Aeroflow Health , a [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 49 - 2025
09/12/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 01 Décembre au 05 Décembre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 49- 2025
09/12/2025
Aggregated presentation by day and by market Statement of transactions in own shares from December 1st to December 05th 2025 Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 novembre 2025
09/12/2025
Nombre total de droits de vote et d’actions composant le capital social au 30 novembre 2025 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2025
09/12/2025
Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
Opus Genetics Announces Positive Recommendation from Independent Data Monitoring Committee for Phase 1/2 Trial in Best Disease
09/12/2025
Initial favorable safety profile demonstrated in OPGx-BEST1 clinical trial RESEARCH TRIANGLE PARK, N.C., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Opus Genetics (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage [...]
Lungpacer Achieves Commercial Milestone as Leading U.S. Hospital Performs First AeroPace® Procedures to Help Patients Liberate from Mechanical Ventilation
09/12/2025
AeroPace temporary transvenous diaphragm neurostimulation system now available to help critically ill patients breathe independently faster EXTON, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Lungpacer Medical , a leader in [...]
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors
09/12/2025
– City of Hope to Evaluate PEDMARK ® for Reducing Ototoxicity in Adult Men with Stage II-III Metastatic Testicular Germ Cell Tumors – – Initiation of Study Reflects Growing Clinical Interest in Addressing the Burden of [...]
Transpire Bio Manufacturing Facility Receives the Establishment Inspection Report Following a Pre-Approval Inspection by the U.S. FDA
09/12/2025
SUNRISE, Fla., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated, clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced [...]
Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx®-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma
09/12/2025
Expert panel offers data-driven guidance for integrating DecisionDx-Melanoma into clinical decision-making for patients with melanoma FRIENDSWOOD, Texas, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. ( [...]
Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel
09/12/2025
Ms. Ishak brings more than 25 years of corporate legal and strategic leadership experience in the life sciences industry CHATHAM, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP [...]
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
09/12/2025
Introduces 2026 full year revenue guidance of $245 million to $285 million, an approximately 15% increase in core revenue growth over 2025, royalty revenue of $200 to $225 million, a 40% increase over 2025 1 , and core [...]

Pages